Title: Cellular impedance assays for predictive preclinical drug screening of kinase inhibitor cardiovascular toxicity.
Journal: Toxicological sciences : an official journal of the Society of Toxicology 20131001
Title: Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors.
Journal: European journal of medicinal chemistry 20090401
Title: Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer.
Journal: Journal of translational medicine 20090101
Title: Synthesis and structure-activity relationships of N-6 substituted analogues of 9-hydroxy-4-phenylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones as inhibitors of Wee1 and Chk1 checkpoint kinases.
Journal: European journal of medicinal chemistry 20080601
Title: 3D-QSAR studies of Checkpoint Kinase Weel inhibitors based on molecular docking, CoMFA and CoMSIA.
Journal: European journal of medicinal chemistry 20080501
Title: 4-Phenylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione inhibitors of the checkpoint kinase Wee1. Structure-activity relationships for chromophore modification and phenyl ring substitution.
Journal: Journal of medicinal chemistry 20060810
Title: Palmer BD, et al. 4-Phenylpyrrolo,4-ccarbazole-1,3(2H,6H)-dione inhibitors of the checkpoint kinase Wee1. Structure-activity relationships for chromophore modification and phenyl ring substitution. J Med Chem. 2006 Aug 10;49(16):4896-911.
Title: Feng L, et al. Discovery of a Small-Molecule BMP Sensitizer for Human Embryonic Stem Cell Differentiation. Cell Rep. 2016 May 31;15(9):2063-75.
Title: Smaill JB, et al. Synthesis and structure-activity relationships of N-6 substituted analogues of 9-hydroxy-4-phenylpyrrolo,4-ccarbazole-1,3(2H,6H)-diones as inhibitors of Wee1 and Chk1 checkpointkinases. Eur J Med Chem. 2008 Jun;43(6):1276-96. Epub 2007 Aug 6.
